HDAC6 and pancreatic neoplasm: In this study, our data demonstrate that HDAC6 is highly expressed in pancreatic cancer and functions together with CLIP-170 to promote the motility of pancreatic cancer cells, suggesting HDAC6 as a potential target for treating this notorious disease.